Publications found:
55,956
Sort by:
Hemostasis Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... 150 tables from Venture Planning Group’s new 7-country study, “Global Hemostasis Diagnostics Market: US, Europe, Japan,” including supplier shares, and forecasts ... Spain UK USA Sales and Market Share Analysis Sales and market shares of major hemostasis testing instrument and reagent suppliers. Market ...
July 2013
Tumor Markers: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... contains 450 tables from Venture Planning Group’s new 7-country study, “Tumor Markers: US, Europe, Japan,” including supplier shares, as well as test volume ... Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker and country. Five-year ...
July 2013
Microbiology Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for over 100 Diseases by Country France, Germany, Italy, Japan, Spain, UK, US
US$ 14,960.00
This DataPack contains 800 tables from Venture Planning Group’s new 7-country study, “Global Microbiology Testing Market: US, Europe, Japan,” including supplier shares, and forecasts for over 100 tests. This DataPack will help current suppliers and potential market entrants identify and ...
July 2013
Transfusion Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares, Forecasts for 40 Typing, Grouping, Screening Tests France, Germany, Italy, Japan, Spain, UK, US
US$ 14,880.00
... and sales forecasts for 40 typing, grouping and infectious disease screening tests. The DataPack will help current suppliers and potential market ... share estimates for leading suppliers of transfusion diagnostic testing products by country. Market Segmentation Analysis Test volume and sales forecasts for ...
July 2013
Infectious Diseases: Granular Analysis of the Global Market Supplier Shares and Forecasts for over 100 Diseases by Country France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... Venture Planning Group new 7-country study, “Competing in the Global Infectious Disease Testing Market,” including supplier shares, and forecasts for ... Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers of infectious disease tests, by country and individual assay. ...
June 2013
800 pages
Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... new 7-country study, “Competing in the Global Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 ... Coverage France Germany Italy Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker ...
June 2013
450 pages
Blood Banking: Granular Analysis of the European Market Supplier Shares, Forecasts for 40 Typing, Grouping, Screening Tests France, Germany, Italy, Spain, UK
US$ 22,400.00
... from Venture Planning Group new 5-country study, “Competing in the European Blood Banking Market,” including supplier shares, as well as test volume and ... and market share estimates for leading suppliers of blood banking products by country. Market Segmentation Analysis Test volume and sales forecasts for ...
June 2013
2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers
US$ 3,080.00
The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, ... technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ...
June 2013
125 pages
2013 Analysis of the European Pap Smear/HPV Market
US$ 2,280.00
This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment. The report examines market ...
June 2013
235 pages
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
US$ 3,600.00
This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...
June 2013
278 pages
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
US$ 6,320.00
This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...
June 2013
318 pages
Analysis of the Enteric Disease Testing Market in the US: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 4,320.00
... suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and ... presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by tests. Also, the report: Examines market ...
June 2013
314 pages
Analysis of the Enteric Disease Testing Market in Europe: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 7,520.00
... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ... report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country. Also, the report: ...
June 2013
363 pages
Analysis of the Respiratory Disease Testing Market in the US: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 3,680.00
... by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, ...
June 2013
282 pages
Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 6,640.00
... . About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ... presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report ...
June 2013
335 pages
2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 3,120.00
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, ...
June 2013
241 pages
2013 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, ...
June 2013
295 pages
2013 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures
US$ 3,160.00
Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following ...
June 2013
277 pages
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs
US$ 1,960.00
... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs” is a unique study designed ...
June 2013
260 pages
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices
US$ 1,960.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market entrants ...
June 2013
262 pages
2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs
US$ 1,960.00
... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs” is a unique study designed ...
June 2013
260 pages
2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs
US$ 2,200.00
... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs” is a unique study designed ...
June 2013
260 pages
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers
US$ 1,960.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique study designed to help current suppliers and potential market entrants ...
June 2013
260 pages
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs
US$ 1,960.00
... resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs” is a unique study ...
June 2013
260 pages
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market ...
June 2013
262 pages
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique study designed to help current suppliers ...
June 2013
300 pages
2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique market and technology assessment ...
June 2013
310 pages